抗流1号对发热患者预防甲型H1N1流感的临床分析

Clinical Research of AI-1 Prevention Influenza Ah1N1 in Fever Patients

目的:研究抗流1号对197例发热患者甲型H1N1流感的预防。方法:体温T≥37.5℃的患者197例,根据患者有无接触甲型H1N1病例,分为密切接触组25例,一般接触组48例,非接触组124例。进行体格检查、查血常规和胸片,服用抗流1号中药制剂(红景天、大青叶、虎仗和贯众),根据症状和病情给予中医辨证治疗或抗生素及抗病毒治疗,观察患者一般情况,比较治疗情况。结果:密切接触组中性粒细胞和淋巴细胞降低的患者明显多于非接触组(P<0.01);用抗病毒治疗的患者密切接触组与非接触组比较有显著差异(P<0.01),中医辨证治疗的患者密切接触组与非接触组比较有差异(P<0.05)。结论:以扶正和清热解毒为主的抗流1号能有效的预防甲型H1N1的传播可以起到降低发病率、减轻病情,值得推广应用。

Objective：To research Anti-Influenza Ah1N1-1（AI-1）prevention influenza Ah1N1 in 197 fever patients.Methods：197 fever patients were divided into 3 groups according to whether exposed to influenza Ah1N1 as close contact group 25 patients,common contact group 48 patients,non-contact group 124 patients.Give all patients AI-1（Gold Theragran,Dyers woad leaf,Huzhang,Cyrtomii rhizoma）,give treatment based on differentiation or antibiotic or anti-virus according to symptom and patient＇s condition.After physical examination,blood cell analysis and chest radiography,summary therapy information.Results：Patients who neutrophil and lymphocyte depress in close contact group were more than non-contact group（P0.01）;Patients who accept anti-virus therapy in close contact group were more than non-contact group（P0.01）;Patients who accept treatment based on differentiation in in close contact group were more than non-contact group（P0.05）.Conclusions：AI-1 thathave effectiveness of strengthen the body resistance and clear awayheat-toxin can prevent propagation of Ah1N1-1,depress disease incidence,abatement pathogenetic condition.It is worth extending and application.